Jason Drew Smith - 31 Jan 2026 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
General Counsel
Signature
/s/ Jason D. Smith, Attorney-in-Fact
Issuer symbol
URGN
Transactions as of
31 Jan 2026
Net transactions value
-$147,262
Form type
4
Filing time
11 Feb 2026, 14:54:58 UTC
Previous filing
09 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Smith Jason Drew General Counsel 400 ALEXANDER PARK DRIVE, PRINCETON /s/ Jason D. Smith, Attorney-in-Fact 11 Feb 2026 0001821479

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction URGN Ordinary Shares Options Exercise +5,500 +11% 55,472 31 Jan 2026 Direct F1
transaction URGN Ordinary Shares Sale $52,257 -2,654 -4.8% $19.69 52,934 03 Feb 2026 Direct F2
transaction URGN Ordinary Shares Options Exercise +3,333 +6% 58,805 31 Jan 2026 Direct F1
transaction URGN Ordinary Shares Sale $31,662 -1,608 -3% $19.69 51,326 03 Feb 2026 Direct F2
transaction URGN Ordinary Shares Options Exercise +6,667 +15% 49,972 31 Jan 2026 Direct F1
transaction URGN Ordinary Shares Sale $63,343 -3,217 -5.5% $19.69 55,588 03 Feb 2026 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Restricted Stock Units Options Exercise $0 -5,500 -50% $0.000000 5,500 31 Jan 2026 Ordinary Shares 5,500 Direct F1, F5
transaction URGN Restricted Stock Units Options Exercise $0 -3,333 -33% $0.000000 6,667 31 Jan 2026 Ordinary Shares 3,333 Direct F1, F3
transaction URGN Restricted Stock Units Options Exercise $0 -6,667 -100% $0.000000 0 31 Jan 2026 Ordinary Shares 6,667 Direct F1, F4
transaction URGN Restricted Stock Units Award $0 +32,609 $0.000000 32,609 31 Jan 2026 Ordinary Shares 32,609 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
F2 Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
F3 The reporting person was granted RSUs on January 31, 2025 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2026.
F4 The reporting person was granted RSUs on January 31, 2023 representing 20,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
F5 The reporting person was granted RSUs on January 31, 2024 representing 16,500 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2025.
F6 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.